Cargando…
Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor
The histone deacetylase inhibitor (HDACI) butyroyloxymethyl diethylphosphate (AN-7) synergizes the cytotoxic effect of doxorubicin (Dox) and anti-HER2 on mammary carcinoma cells while protecting normal cells against their insults. This study investigated the concomitant changes occurring in heart ti...
Autores principales: | Tarasenko, Nataly, Cutts, Suzanne M., Phillips, Don R., Inbal, Aida, Nudelman, Abraham, Kessler-Icekson, Gania, Rephaeli, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285631/ https://www.ncbi.nlm.nih.gov/pubmed/22384017 http://dx.doi.org/10.1371/journal.pone.0031393 |
Ejemplares similares
-
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer
por: Tarasenko, Nataly, et al.
Publicado: (2021) -
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007) -
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
por: Moyal, Lilach, et al.
Publicado: (2016) -
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model
por: Dahbash, Mor, et al.
Publicado: (2019) -
Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity
por: Sedeman, Megan, et al.
Publicado: (2022)